drugset / Trial / NCT05828758

Amoxicillin for Enteral Nutrition Intolerance in Pediatric Intensive Care Unit

NCT05828758

Phase 2/3 Unknown 90 enrolled Sohag University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The goal of this randomized controlled study is to investigate the efficacy of enteral amoxicillin for the treatment of children with feeding intolerance in pediatric intensive care unit. Children with feeding intolerance will be randomized into study and comparison groups. The study group will receive amoxicillin 10 mg/kg by nasogastric tube 3 times daily 10 minutes before bolus gastric feeding for 7 days. The comparison group will receive equal volume of distilled water as a placebo. The primary outcome will be the improvement of feeding intolerance on day 7 study timepoint.

Timeline

Start
2023-04-24
Primary completion
2024-05-01
Completion
2024-05-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified 10 mg/kg Other

Indications

No indication recorded.